These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2657745)

  • 1. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.
    Lombardi G; Sidhu S; Batchelor JR; Lechler RI
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4190-4. PubMed ID: 2657745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between MHC restricted and allospecific T cell recognition.
    Lechler R; Batchelor R; Lombardi G
    Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells.
    Sidhu S; Deacock S; Bal V; Batchelor JR; Lombardi G; Lechler RI
    J Exp Med; 1992 Sep; 176(3):875-80. PubMed ID: 1512550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
    Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
    Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specificity of alloreactive T cells is determined by MHC polymorphisms which contact the T cell receptor and which influence peptide binding.
    Lombardi G; Barber L; Sidhu S; Batchelor JR; Lechler RI
    Int Immunol; 1991 Aug; 3(8):769-75. PubMed ID: 1911546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones.
    Lombardi G; Sidhu S; Lamb JR; Batchelor JR; Lechler RI
    J Immunol; 1989 Feb; 142(3):753-9. PubMed ID: 2492329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence for the recognition of endogenous peptides by autoreactive T cell clones.
    Rees AD; Lombardi G; Scoging A; Barber L; Mitchell D; Lamb J; Lechler R
    Int Immunol; 1989; 1(6):624-30. PubMed ID: 2489049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence.
    Lombardi G; Barber L; Aichinger G; Heaton T; Sidhu S; Batchelor JR; Lechler RI
    J Immunol; 1991 Sep; 147(6):2034-40. PubMed ID: 1716292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
    de Koster HS; van Rood JJ; Termijtelen A
    Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of TCR-alpha beta sequences of cross-reactive anti-DR alloreactive T-cell clones: identification of possible contact residues based on charge complementarity between TCR chains and DR determinants.
    Champagne E; Essaket S; Huchenq A; Fabron J; Coppin HL; Sevin J; Thomsen M
    Eur J Immunogenet; 1992; 19(1-2):21-31. PubMed ID: 1533151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.
    Liu Z; Sun YK; Xi YP; Harris P; Suciu-Foca N
    J Exp Med; 1992 Jun; 175(6):1663-8. PubMed ID: 1375267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell recognition of allopeptides in context of syngeneic MHC.
    Liu Z; Braunstein NS; Suciu-Foca N
    J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic recognition of HLA-DRB1*0406 by T cells with HLA-DRB1*0403: role of amino acid residue 37 on the beta sheet in T cell recognition.
    Kaneko T; Obata F
    Immunobiology; 1996 Aug; 195(3):261-70. PubMed ID: 8877401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel T-cell-defined HLA-DR polymorphism not predicted from the linear amino acid sequence.
    Termijtelen A; van den Elsen P; Koning F; de Koster S; Schroeijers W; Vanderkerckhove B
    Hum Immunol; 1989 Sep; 26(1):47-58. PubMed ID: 2476425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.